<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">scbmt</journal-id><journal-title-group><journal-title xml:lang="ru">БИОМЕДИЦИНА</journal-title><trans-title-group xml:lang="en"><trans-title>Journal Biomed</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-5982</issn><issn pub-type="epub">2713-0428</issn><publisher><publisher-name>Scientific center of biomedical technologies of Federal Medical and Biological Agency</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">scbmt-786</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>К вопросу значения исследования полиморфного
маркера ARG16GLY гена ADRB2, кодирующего
бета2-адренорецепторы при проведении
токолитической терапии бета2-адреностимуляторами
у беременных</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сокова</surname><given-names>Е. А.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Прилуцкий</surname><given-names>А. В.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макулова</surname><given-names>О. И.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Институт клинической фармакологии, Москва</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>1Женская консультации № 15, Москва</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>13</day><month>02</month><year>2020</year></pub-date><volume>1</volume><issue>3</issue><fpage>141</fpage><lpage>143</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сокова Е.А., Прилуцкий А.В., Макулова О.И., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Сокова Е.А., Прилуцкий А.В., Макулова О.И.</copyright-holder><copyright-holder xml:lang="en">Сокова Е.А., Прилуцкий А.В., Макулова О.И.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.scbmt.ru/jour/article/view/786">https://journal.scbmt.ru/jour/article/view/786</self-uri></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">De Heus R, Mol BW, Erwich J-JH, et al. Adverse drug reactions totocolytic treatment for preterm labour: prospective cohort study // BMJ. - 2009;338:b744.</mixed-citation><mixed-citation xml:lang="en">De Heus R, Mol BW, Erwich J-JH, et al. Adverse drug reactions totocolytic treatment for preterm labour: prospective cohort study // BMJ. - 2009;338:b744.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Серов В.Н., Тютюнник В.Л. Тактика лечения угрожающих преждев- ременных родов // РМЖ. - 2008. - Том 16. - № 19.</mixed-citation><mixed-citation xml:lang="en">Серов В.Н., Тютюнник В.Л. Тактика лечения угрожающих преждев- ременных родов // РМЖ. - 2008. - Том 16. - № 19.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Palmer C.N.A., Lipworth B.J., Lee et al. Arginine-16 β2 adrenjrecepor genotype predisposes to exacerbations in young asthmatics taking regular salmaterol // Thorax. - 2006. -Vol.61. - р. 940-944.</mixed-citation><mixed-citation xml:lang="en">Palmer C.N.A., Lipworth B.J., Lee et al. Arginine-16 β2 adrenjrecepor genotype predisposes to exacerbations in young asthmatics taking regular salmaterol // Thorax. - 2006. -Vol.61. - р. 940-944.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Landau R, Xie HG, Dishy V, Stein CM, et al. Beta2-Adrenergic receptor genotype and preterm delivery // Am J Obstet Gynecol. - 2002. - Vol.187. - P.1294-1298.</mixed-citation><mixed-citation xml:lang="en">Landau R, Xie HG, Dishy V, Stein CM, et al. Beta2-Adrenergic receptor genotype and preterm delivery // Am J Obstet Gynecol. - 2002. - Vol.187. - P.1294-1298.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Landau R, Michel M.A, Stylianos A.E., Jean-Louis B.,et al. Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2- agonist tocolysis for preterm labor // Clin Pharmacol Ther. - 2005. - Vol.78 (6). - P. 656-663.</mixed-citation><mixed-citation xml:lang="en">Landau R, Michel M.A, Stylianos A.E., Jean-Louis B.,et al. Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2- agonist tocolysis for preterm labor // Clin Pharmacol Ther. - 2005. - Vol.78 (6). - P. 656-663.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
